NORD Holding has acquired HKS health solutions GmbH, enhancing its position in the European CDMO market as part of a strategic Buy-and-Build approach.
Target Company Information
NORD Holding has acted as the exclusive Debt Advisor for NETWORK in structuring and negotiating the acquisition financing for HKS health solutions GmbH ("HKS"), a leading contract manufacturer of high-quality dietary supplements and pharmaceuticals. This transaction represents a significant step in the Buy-and-Build strategy under the newly established 1Q Health Group, following the acquisition of ABJ alive GmbH in March 2024.
The deal builds upon the previous acquisition of ABJ alive, where NETWORK also served as the exclusive Debt Advisor. This add-on acquisition further strengthens NORD Holding's commitment to establishing the 1Q Health Group as a leading European Contract Development and Manufacturing Organization (CDMO) for dietary supplements and pharmaceuticals.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The dietary supplement and pharmaceutical manufacturing industry in Germany is robust and continues to grow, driven by increasing health awareness and the demand for high-quality products. With a strong regulatory framework and high standards like
Similar Deals
Saesco Medical → Rivolution GmbH
2025
Calibre Scientific → DCS Innovative Diagnostik-Systeme GmbH & Co. KG
2024
Ank-Kaiser Sanitätshaus GmbH → Sanitätshaus Mayer & Rexing GmbH
2024
NORD Holding
invested in
HKS health solutions GmbH
in 2024
in a Buy & Build / Roll-Up deal